Stada targets more than 30 pct core earnings growth in 2019

July 11, 2016 11:39 AM

14 0

FRANKFURT, July 11 Stada issued a target for more than 30 percent growth in adjusted core earnings in 2019 as the German generic drugmaker faces criticism from an activist investor.

The group, which also makes consumer care products and diagnostic kits, said on Monday it was aiming for 510 million euros ($563.65 million) in 2019 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, up from 389.4 million euros last year.

Also read: GM posts best 3Q results since exiting bankruptcy

Read more

To category page